Blog & Commentary
Simmons Hanly Conroy’s support blog is a place for clients and families to find news, education, and inspirational stories about the following areas of litigation: mesothelioma and asbestos, dangerous drugs and devices, consumer protection and mass torts, personal injury and environmental litigation.
Blog
Asbestos and Mesothelioma News Wrap Up: December 2014
The mesothelioma lawyers at Simmons Hanly Conroy understand the importance of staying up to date on the latest asbestos and mesothelioma news. Below is a group of some of the most recent… Read More
FDA Advisers Shown to Have Questionable Financial Ties
In July 2014, an adviser on a U.S. Food and Drug Administration (FDA) gynecology panel stepped down after he was questioned about conflicts of interest. It was later discovered that this panel… Read More
The History of Risperdal FDA Warnings
Risperdal was approved by the U.S. Food and Drug Administration (FDA) in 1994. It is recognized as a medication used to treat psychological issues. The antipsychotic drug is approved for use in patients… Read More
Get to Know the Simmons Hanly Conroy Shareholders – Part 2
In October, we introduced ten members of the Simmons Hanly Conroy leadership team. Now it’s time to introduce ten more. By getting to know our shareholders, you can see for yourself the… Read More
Blood Thinners Like Xarelto and Pradaxa Classified as “Dangerous”: Here’s Why
Both Xarelto and Pradaxa are popular blood thinners prescribed to reduce the risk of blood clots that can cause a stroke or heart attack. These types of medications, however, come with serious… Read More
Holiday Storage in Attics and Asbestos Exposure: What to Know
It’s that time of year – people are heading upstairs to the attic or other storage space to fumble through their holiday décor and wrapping essentials. They’re pulling out boxes, shifting large… Read More
Asbestos and Mesothelioma News Wrap Up: November 2014
Here at Simmons Hanly Conroy, our asbestos attorneys want to keep you up to date on the latest asbestos and mesothelioma news. Below is a list of some of the most recent… Read More
Pharmaceutical News Wrap Up: November 2014
Here at Simmons Hanly Conroy, our pharmaceutical lawyers understand the importance of staying up to date on the latest pharmaceutical news. Below is a list of some of the most recent headlines concerning… Read More
6 Grain Industry Businesses Impacted by Viptera® Corn
Sales of Syngenta’s Agrisure Viptera® corn prior to approval for import by China has damaged the U.S. corn industry. The National Grain and Feed Association (NGFA) has estimated that the U.S. corn… Read More
4 Ways Farmers Were Negatively Affected by Viptera® Corn
Syngenta’s Agrisure Viptera® and Duracade™ corn have significantly hurt American farmers. The corn has the genetically modified trait MIR 162, which was never approved by China. Syngenta continued to sell Viptera® and Duracade™, despite… Read More